76 related articles for article (PubMed ID: 17970030)
1. Effect of molecular chirality and side chain bulkiness on angiogenesis of haloacetylcarbamoyl-2-nitroimidazole compounds.
Ohkura K; Uto Y; Nagasawa H; Hori H
Anticancer Res; 2007; 27(6A):3693-700. PubMed ID: 17970030
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers.
Jin CZ; Nagasawa H; Shimamura M; Uto Y; Inayama S; Takeuchi Y; Kirk KL; Hori H
Bioorg Med Chem; 2004 Sep; 12(18):4917-27. PubMed ID: 15336271
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between Radiosensitizing Activity and the Stereo-structure of the TX-2036 Series of Molecules.
Ohkura K; Tabata A; Uto Y; Hori H
Anticancer Res; 2019 Aug; 39(8):4479-4483. PubMed ID: 31366548
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacetylcarbamoyl-2-nitroimidazoles.
Hori H; Jin CZ; Kiyono M; Kasai S; Shimamura M; Inayama S
Bioorg Med Chem; 1997 Mar; 5(3):591-9. PubMed ID: 9113337
[TBL] [Abstract][Full Text] [Related]
5. Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.
Uto Y; Nagasawa H; Jin CZ; Nakayama S; Tanaka A; Kiyoi S; Nakashima H; Shimamura M; Inayama S; Fujiwara T; Takeuchi Y; Uehara Y; Kirk KL; Nakata E; Hori H
Bioorg Med Chem; 2008 Jun; 16(11):6042-53. PubMed ID: 18474428
[TBL] [Abstract][Full Text] [Related]
6. Structure-associated Functional Control of TX-1877 Series by Glyco-conjugation.
Ohkura K; Kawaguchi Y; Tatematsu Y; Tabata A; Uto Y; Hori H
Anticancer Res; 2018 Jul; 38(7):4241-4245. PubMed ID: 29970557
[TBL] [Abstract][Full Text] [Related]
7. Exploring unique structures: flexibility is a significant factor in biological activity.
Ohkura K
Biol Pharm Bull; 2007 Jun; 30(6):1025-36. PubMed ID: 17541149
[TBL] [Abstract][Full Text] [Related]
8. Effect of Isomerization of TX-2036 Derivatives on the Interaction With Tyrosine Kinase Domain of EGF Receptor.
Ohkura K; Tabata A; Uto Y; Hori H
Anticancer Res; 2020 Aug; 40(8):4675-4680. PubMed ID: 32727791
[TBL] [Abstract][Full Text] [Related]
9. TX-2152: a conformationally rigid and electron-rich diyne analogue of FTY720 with in vivo antiangiogenic activity.
Nakayama S; Uto Y; Tanimoto K; Okuno Y; Sasaki Y; Nagasawa H; Nakata E; Arai K; Momose K; Fujita T; Hashimoto T; Okamoto Y; Asakawa Y; Goto S; Hori H
Bioorg Med Chem; 2008 Aug; 16(16):7705-14. PubMed ID: 18678496
[TBL] [Abstract][Full Text] [Related]
10. Total synthesis and antiangiogenic activity of cyclopentane analogues of fumagillol.
Jeong BS; Choi NS; Ahn SK; Bae H; Kim HS; Kim D
Bioorg Med Chem Lett; 2005 Aug; 15(15):3580-3. PubMed ID: 15978809
[TBL] [Abstract][Full Text] [Related]
11. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
12. Syntheses of fumagillin and ovalicin.
Yamaguchi J; Hayashi Y
Chemistry; 2010 Apr; 16(13):3884-901. PubMed ID: 20209516
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
Jung M; Tak J; Chung WY; Park KK
Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
[TBL] [Abstract][Full Text] [Related]
14. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.
Lu J; Chong CR; Hu X; Liu JO
J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic hypoxic cytotoxin TX-402 inhibits hypoxia-inducible factor 1 signaling pathway.
Nagasawa H; Mikamo N; Nakajima Y; Matsumoto H; Uto Y; Hori H
Anticancer Res; 2003; 23(6a):4427-34. PubMed ID: 14666730
[TBL] [Abstract][Full Text] [Related]
16. Raman optical activity spectra and conformational elucidation of chiral drugs. The case of the antiangiogenic aeroplysinin-1.
Nieto-Ortega B; Casado J; Blanch EW; López Navarrete JT; Quesada AR; Ramírez FJ
J Phys Chem A; 2011 Apr; 115(13):2752-5. PubMed ID: 21401047
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics of human-specific cytolysin: analysis of membrane binding motif for therapeutic application.
Ohkura K; Hori H; Nagamune H
Anticancer Res; 2006; 26(6A):4055-62. PubMed ID: 17195457
[TBL] [Abstract][Full Text] [Related]
18. The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer.
Miyake K; Shimada M; Nishioka M; Sugimoto K; Batmunkh E; Uto Y; Nagasawa H; Hori H
Cancer Lett; 2008 Dec; 272(2):325-35. PubMed ID: 18762366
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2).
Garrabrant T; Tuman RW; Ludovici D; Tominovich R; Simoneaux RL; Galemmo RA; Johnson DL
Angiogenesis; 2004; 7(2):91-6. PubMed ID: 15516829
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
